Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Highlight Event and Entertainment AG publishes results for the first half of 2023
Highlight Event and Entertainment AG publishes results for the first half of 2023
Highlight Event and Entertainment AG publishes results for the first half of 2023
Changes in the Board of Directors of Swiss Steel Group
Changes in the Board of Directors of Swiss Steel Group
Changes in the Board of Directors of Swiss Steel Group
Romande Energie Group 2023 half-year results and restatement of financial statements as at 31 December 2022
Romande Energie Group 2023 half-year results and restatement of financial statements as at 31 December 2022
Romande Energie Group 2023 half-year results and restatement of financial statements as at 31 December 2022
Edisun Power Europe AG: Solid performance despite headwinds
Edisun Power Europe AG: Solid performance despite headwinds
Edisun Power Europe AG: Solid performance despite headwinds
Ad hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group recorded successful first half of the year / CEO Urs Kessler to step down in June 2025
Ad hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group recorded successful first half of the year / CEO Urs Kessler to step down in June 2025
Ad hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group recorded successful first half of the year / CEO Urs Kessler to step down in June 2025
2022/23 financial year: dormakaba shows strong organic growth driven by price and continued sequential improvements
2022/23 financial year: dormakaba shows strong organic growth driven by price and continued sequential improvements
2022/23 financial year: dormakaba shows strong organic growth driven by price and continued sequential improvements
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
EQS-News: Highlight Group publishes results for the first half of 2023
EQS-News: Highlight Group publishes results for the first half of 2023
EQS-News: Highlight Group publishes results for the first half of 2023
Baloise wins two Red Dot Design Awards
Baloise wins two Red Dot Design Awards
Baloise wins two Red Dot Design Awards
Significant shareholder places shares with institutional investors
Significant shareholder places shares with institutional investors
Significant shareholder places shares with institutional investors
Press release: Leonteq's ESG rating upgraded to AA by MSCI
Press release: Leonteq's ESG rating upgraded to AA by MSCI
Press release: Leonteq's ESG rating upgraded to AA by MSCI
Burkhalter Group announces successful completion of capital increase
Burkhalter Group announces successful completion of capital increase
Burkhalter Group announces successful completion of capital increase
Investis posts strong operating results for the first half year – lower portfolio valuation
Investis posts strong operating results for the first half year – lower portfolio valuation
Investis posts strong operating results for the first half year – lower portfolio valuation
Phoenix Mecano streamlines portfolio
Phoenix Mecano streamlines portfolio
Phoenix Mecano streamlines portfolio
Gebhard Giselbrecht becomes new CEO of Bellevue Group
Gebhard Giselbrecht becomes new CEO of Bellevue Group
Gebhard Giselbrecht becomes new CEO of Bellevue Group
HIAG's business model is convincing in a market dominated by rising interest rates
Sustainability-linked, committed syndicated credit facility placed
HIAG's business model is convincing in a market dominated by rising interest rates Sustainability-linked, committed syndicated credit facility placed
HIAG's business model is convincing in a market dominated by rising interest rates Sustainability-linked, committed syndicated credit facility placed
Kinarus Therapeutics signed licensing agreement to extend cash for operations
Kinarus Therapeutics signed licensing agreement to extend cash for operations
Kinarus Therapeutics signed licensing agreement to extend cash for operations
Update regarding the public tender offer for Schaffner shares
Update regarding the public tender offer for Schaffner shares
Update regarding the public tender offer for Schaffner shares
Pay within 30 days with TWINT
Pay within 30 days with TWINT
Pay within 30 days with TWINT
Solid operating results in a challenging market environment
Solid operating results in a challenging market environment
Solid operating results in a challenging market environment
Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
Swiss Prime Site with strong operating results
Swiss Prime Site with strong operating results
Swiss Prime Site with strong operating results